A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
Clinical trial NCT04161430 · COMPLETED
Trial details
- NCT number
- NCT04161430
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-02
- Primary completion
- 2022-06-27
- Enrollment
- 766
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.